OTC drug "feedback" meeting
This article was originally published in The Tan Sheet
Executive Summary
Warner-Lambert development and regulatory execs to meet with FDA on Oct. 8 at 10 a.m. in Rockville, Md. to discuss the regulatory pathway for producing a product that combines elements of the anticaries and oral health monographs. The firm presented a proposed testing protocol for a Listerine antiplaque/antigingivitis toothpaste before FDA's Dental Plaque Subcommittee last year (1"The Tan Sheet" June 1, 1998, p. 1)